Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Pharmacokinetic assessment of dapivirine vaginal microbicide gel in healthy, HIV-negative women.

Nel AM, Coplan P, Smythe SC, McCord K, Mitchnick M, Kaptur PE, Romano J.

AIDS Res Hum Retroviruses. 2010 Nov;26(11):1181-90. doi: 10.1089/aid.2009.0227. Epub 2010 Sep 21.

PMID:
20854207
[PubMed - indexed for MEDLINE]
2.

Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women.

Nel AM, Coplan P, van de Wijgert JH, Kapiga SH, von Mollendorf C, Geubbels E, Vyankandondera J, Rees HV, Masenga G, Kiwelu I, Moyes J, Smythe SC.

AIDS. 2009 Jul 31;23(12):1531-8. doi: 10.1097/QAD.0b013e32832c413d.

PMID:
19550287
[PubMed - indexed for MEDLINE]
3.

Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring.

Romano J, Variano B, Coplan P, Van Roey J, Douville K, Rosenberg Z, Temmerman M, Verstraelen H, Van Bortel L, Weyers S, Mitchnick M.

AIDS Res Hum Retroviruses. 2009 May;25(5):483-8. doi: 10.1089/aid.2008.0184.

PMID:
19388819
[PubMed - indexed for MEDLINE]
4.

Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel.

Nel AM, Smythe SC, Habibi S, Kaptur PE, Romano JW.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):161-9. doi: 10.1097/QAI.0b013e3181e3293a.

PMID:
20574411
[PubMed - indexed for MEDLINE]
5.

Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women.

Nel A, Smythe S, Young K, Malcolm K, McCoy C, Rosenberg Z, Romano J.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):416-23.

PMID:
19623693
[PubMed - indexed for MEDLINE]
6.

Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days.

Nuttall JP, Thake DC, Lewis MG, Ferkany JW, Romano JW, Mitchnick MA.

Antimicrob Agents Chemother. 2008 Mar;52(3):909-14. Epub 2007 Dec 17.

PMID:
18086845
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study.

O'Loughlin J, Millwood IY, McDonald HM, Price CF, Kaldor JM, Paull JR.

Sex Transm Dis. 2010 Feb;37(2):100-4. doi: 10.1097/OLQ.0b013e3181bc0aac.

PMID:
19823111
[PubMed - indexed for MEDLINE]
8.

Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers.

Jespers VA, Van Roey JM, Beets GI, Buvé AM.

J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):154-8.

PMID:
17106275
[PubMed - indexed for MEDLINE]
9.

A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women.

Nel A, Haazen W, Nuttall J, Romano J, Rosenberg Z, van Niekerk N.

AIDS. 2014 Jun 19;28(10):1479-87. doi: 10.1097/QAD.0000000000000280.

PMID:
24901365
[PubMed - in process]
10.

A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women.

Van Damme L, Wright A, Depraetere K, Rosenstein I, Vandersmissen V, Poulter L, McKinlay M, Van Dyck E, Weber J, Profy A, Laga M, Kitchen V.

Sex Transm Infect. 2000 Apr;76(2):126-30.

PMID:
10858715
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.

Mbopi-Keou FX, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere JF, Domingo MC, Piret J, Tsague L, Zekeng L, Mwatha A, Mâsse B, Bergeron MG.

Contraception. 2009 Nov;80(5):484-92. doi: 10.1016/j.contraception.2009.03.020. Epub 2009 May 23.

PMID:
19835725
[PubMed - indexed for MEDLINE]
12.

A dose-ranging phase I study of dextrin sulphate, a vaginal microbicide, in HIV-negative and HIV-positive female volunteers.

McCormack S, Jespers V, Low-Beer N, Gabe R, Kaganson N, Chapman A, Nunn A, Lacey C, Van Damme L.

Sex Transm Dis. 2005 Dec;32(12):765-70.

PMID:
16314774
[PubMed - indexed for MEDLINE]
13.

SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans.

Price CF, Tyssen D, Sonza S, Davie A, Evans S, Lewis GR, Xia S, Spelman T, Hodsman P, Moench TR, Humberstone A, Paull JR, Tachedjian G.

PLoS One. 2011;6(9):e24095. doi: 10.1371/journal.pone.0024095. Epub 2011 Sep 15.

PMID:
21935377
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

UC781 microbicide gel retains anti-HIV activity in cervicovaginal lavage fluids collected following twice-daily vaginal application.

Haaland RE, Evans-Strickfaden T, Holder A, Pau CP, McNicholl JM, Chaikummao S, Chonwattana W, Hart CE.

Antimicrob Agents Chemother. 2012 Jul;56(7):3592-6. doi: 10.1128/AAC.00452-12. Epub 2012 Apr 16.

PMID:
22508307
[PubMed - indexed for MEDLINE]
Free PMC Article
15.
16.

Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.

Vaughan D, Speed J, Medve R, Andrews JS.

Clin Ther. 2010 Jan;32(1):146-60. doi: 10.1016/j.clinthera.2010.01.006.

PMID:
20171420
[PubMed - indexed for MEDLINE]
17.

Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone.

Sullivan JT, Woodruff M, Lettieri J, Agarwal V, Krol GJ, Leese PT, Watson S, Heller AH.

Antimicrob Agents Chemother. 1999 Nov;43(11):2793-7.

PMID:
10543767
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Fourteen-day safety and acceptability study of the universal placebo gel.

Schwartz JL, Ballagh SA, Kwok C, Mauck CK, Weiner DH, Rencher WF, Callahan MM.

Contraception. 2007 Feb;75(2):136-41. Epub 2006 Oct 25.

PMID:
17241844
[PubMed - indexed for MEDLINE]
19.

Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits.

Clark MR, Friend DR.

AIDS Res Hum Retroviruses. 2012 Nov;28(11):1458-66. doi: 10.1089/AID.2011.0328. Epub 2012 Apr 17.

PMID:
22394281
[PubMed - indexed for MEDLINE]
20.

Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.

Yang J, Li L, Jin H, Tan S, Qiu J, Yang L, Ding Y, Jiang ZH, Jiang S, Liu S.

AIDS Res Hum Retroviruses. 2012 Nov;28(11):1498-508. doi: 10.1089/AID.2012.0084. Epub 2012 Sep 11.

PMID:
22867271
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk